First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl

Autor: Martin, Kevin J., Juppner, Harald, Sherrard, Donald J., Goodman, William G., Kaplan, Mark R., Nassar, George, Campbell, Patricia, Curzi, Mario, Harytan, Chaim C., Mccary, Laura C., Guo, Matthew D., Turner, Stewart A., Bushinsky, David A. ^*

Publikováno v: In Kidney International September 2005 68(3):1236-1243

Smoking in adult survivors of childhood acute lymphoblastic leukemia.

Autor: Tao, May L., Guo, Matthew D., Weiss, Robert, Byrne, Julianne, Mills, James L., Robison, Leslie L., Zeltzer, Lonnie K., Tao, M L, Guo, M D, Weiss, R, Byrne, J, Mills, J L, Robison, L L, Zeltzer, L K

Publikováno v: JNCI: Journal of the National Cancer Institute; 02/04/98, Vol. 90 Issue 3, p219-225, 7p, 2 Charts, 2 Graphs

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.

Autor: Lindberg JS; New Orleans Nephrology Associates, 4228 Houma Boulevard, Metairie, LA 70006, USA. jlindberg@bellsouth.net, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW

Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2005 Mar; Vol. 16 (3), pp. 800-7. Date of Electronic Publication: 2005 Feb 02.

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.

Autor: Shoback DM; Department of Medicine, Veterans Affairs Medical Center, University of California-San Francisco, San Francisco, California 94121, USA. Dolores@itsa.ucsf.edu, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2003 Dec; Vol. 88 (12), pp. 5644-9.